Joint Venture Facilities, Agreement Terminations, Promotions, Appointments, and Collaboration Expansions - Analyst Notes on Dow, Cameco, Ultra, AngloGold Ashanti, and Amyris

NEW YORK, April 4, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding The Dow Chemical Company (NYSE: DOW), Cameco Corp. (NYSE: CCJ), Ultra Petroleum Corp. (NYSE: UPL), AngloGold Ashanti Ltd. (NYSE: AU), and Amyris, Inc. (NASDAQ: AMRS). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

The Dow Chemical Company Analyst Notes 

On March 31, 2014, The Dow Chemical Company (Dow) announced the successful start-up of its joint venture facility membrane chlor-alkali facility with Mitsui & Co., Ltd. of Tokyo, Japan (Mitsui). According to the Company, its share of the chlorine produced at the Dow-Mitsui Chlor-Alkali Freeport, Texas, facility will meet the feedstock needs of the Company's performance- and market-driven businesses. Dow added that it will also market the caustic soda on behalf of the joint venture. Dow Executive Vice President James R. Fitterling commented, "This world-class facility allows us to capitalize on our modern and efficient membrane chlor-alkali technology and serves as a real-life proof point of how new, competitive energy resources in the U.S. are re-shaping the landscape of U.S. Gulf Coast manufacturing. This joint venture bolsters the integration strength of the chlorine value chain at the Freeport site in a capital efficient model that allows Dow to invest in more downstream technology and customer-driven businesses with higher and more consistent earnings." The full analyst notes on The Dow Chemical Company are available to download free of charge at:

http://www.AnalystsReview.com/04042014/DOW/report.pdf

Cameco Corp. Analyst Notes 

On March 31, 2014, Cameco Corp. (Cameco) announced that effective December 31, 2014 its toll-conversion agreement with Springfields Fuels Ltd. (SFL) will be terminated. According to the Company, it signed a 10-year toll-conversion agreement with SFL in 2005 to process up to 5 million kilograms of uranium every year at the Springfields conversion facility in Lancashire, United Kingdom. The Company stated that it settled to pay $18 million to SFL to end the agreement, which was set to expire in 2016. In addition, the Company mentioned that its production at the Springfields facility will end by August 31, 2014. Tim Gitzel, President and CEO of Cameco, said, "With the current weak market for UF₆ conversion we can meet our customer requirements from our Port Hope conversion facility and benefit from better utilization of existing assets." The full analyst notes on Cameco Corp. are available to download free of charge at:

http://www.AnalystsReview.com/04042014/CCJ/report.pdf

Ultra Petroleum Corp. Analyst Notes 

On April 1, 2014, Ultra Petroleum Corp. (Ultra) announced William Picquet's intention to retire as Senior Vice President of Operations. Ultra added that he will serve in a non-executive advisory capacity until his effective retirement date of April 30, 2014. The Company further announced that its Board of Directors has promoted Brad Johnson to the position of Senior Vice President, Operations, effective April 1, 2014. Commenting on Mr. Picquet's retirement, Michael D. Watford, Ultra's Chairman, President and CEO, stated, "We are grateful for Bill's leadership and wisdom he displayed each and every day. He has left an indelible mark on all of us and we will miss him. Having known Bill for almost 25 years, I want to personally thank him for his loyalty and dedicated service to Ultra and wish him well in his retirement." The full analyst notes on Ultra Petroleum Corp. are available to download free of charge at:

http://www.AnalystsReview.com/04042014/UPL/report.pdf

AngloGold Ashanti Ltd. Analyst Notes 

On March 25, 2014, AngloGold Ashanti Ltd. (AngloGold Ashanti) announced the appointment of David L. Hodgson to its board of directors. According to the Company, Mr. Hodgson will be an independent non-executive director, effective April 25, 2014. AngloGold Ashanti mentioned that Mr. Hodgson previously served as the Company's Chief Operating Officer from November 2001 to April 2005, after which he retired. In addition, the Company said that Mr. Hodgson also served Anglo American and De Beers group of companies for three decades in a series of senior and executive positions. AngloGold Ashanti's Chairman of the Board of Directors, commented, "I'm delighted to welcome Mr Hodgson to the Board. His depth of operating and board experience will be a tremendous asset to our business." The full analyst notes on AngloGold Ashanti Ltd. are available to download free of charge at:

http://www.AnalystsReview.com/04042014/AU/report.pdf

Amyris, Inc. Analyst Notes 

On March 31, 2014, Amyris, Inc. (Amyris) announced the expansion and extension of its ongoing collaboration with Kuraray Co., Ltd. (Kuraray) in high performance polymers using Amyris' Biofene® brand of renewable farnesene. The Company stated that according to the transaction agreements, the duration of research and development portion of the collaboration between the Companies will be extended for at least two more years. In addition, the Company said that over the next two years, it will receive an undisclosed amount of collaboration funding, and approximately $4 million worth of Amyris' common stock will be purchased by Kuraray in April 2014. The full analyst notes on Amyris, Inc. are available to download free of charge at:

http://www.AnalystsReview.com/04042014/AMRS/report.pdf

About Analysts Review
We provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

=============

EDITOR NOTES: 

• This is not company news. We are an independent source and our views do not reflect the companies mentioned.
• Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
• This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
• If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] AnalystsReview.com.
• For any urgent concerns or inquiries, please contact us at compliance [at] AnalystsReview.com.
• Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] AnalystsReview.com for consideration.

COMPLIANCE PROCEDURE 

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Analysts Review in this article or report according to the Procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE 

Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED 

Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

http://www.AnalystsReview.com/

SOURCE Analysts Review